Navigation Links
Speech-language researcher awarded top honors
Date:12/6/2012

dered when evaluating the quality and credibility of evidence available to support clinical recommendations. The approach grew out of awareness of the limitations of expert opinion as the basis for making decisions regarding the assessment and treatment of individuals with communication and other disorders. Dollaghan's Handbook of Evidence-Based Practice in Communication Disorders is widely used by researchers, clinicians, faculty and students.

Dollaghan's work is credited with changing the course of research and clinical care in areas examining the mechanisms of word learning and the diagnostic assessments of child language, as well as recovery of communication skills in children who suffered traumatic brain injury.

She helped develop a nonword repetition test that is now a common tool for identifying language processing deficits in children from differing socioeconomic backgrounds.

"Through Dr. Dollaghan's research, we have a better understanding of the word-learning difficulty children with language disorders experience," wrote Dr. Jon Miller, professor emeritus of the University of Wisconsin-Madison and author of a letter to ASHA supporting the nomination. "She found they take away less information about a new word heard only once, affecting both comprehension and production skills. Follow-up research revealed that a relatively simple task, repeating non-words, balanced for phonetic content, was a highly sensitive indicator of language disorder. This focused attention on evaluating basic language learning processes that can be assessed early in development."

Dollaghan has written many book chapters and journal articles and presented at conferences throughout the world. She has served as chairman of the ASHA's Science Advisory Board since 2008 and is an ASHA Fellow.

Dr. Ray Kent, professor emeritus at the University of Wisconsin-Madison, also helped nominate Dollaghan. He lauded her commitment to the profession and to
'/>"/>

Contact: Emily Martinez
emily.martinez@utdallas.edu
214-905-3049
University of Texas at Dallas
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Continuing Education Provider HomeCEUConnection.com Announces New Speech-Language Pathology Live Webinar
2. Researchers craft tool to minimize threat of endocrine disruptors in new chemicals
3. Researchers discover regulator linking exercise to bigger, stronger muscles
4. Prenatal tests more informative using microarray technology, find GW researchers
5. Akron researchers devise Rx for ailing wellness programs
6. Studying marrow, URMC researchers accelerate blood stem cells
7. UNM Cancer Center researchers study new target for breast cancer
8. UIC researcher receives $1.6 million grant to study how exercise affects bone strength
9. Barrow researchers successfully destroy brain tumor cells
10. Western University researchers make breakthrough in arthritis research
11. Researchers report first success of targeted therapy in most common non-small cell lung cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... be given to healthy volunteers in the UK, The ... of an series of safety trials of potential vaccines ... than 1,400 people in the current outbreak in West ... co-developed by the US National Institutes of Health (NIH) ... an international consortium in response to the Ebola epidemic, ...
(Date:8/28/2014)... Catalent Pharma Solutions, the leading global ... for drugs, biologics and consumer health products, today ... Services, and Chris Greco, Manager, Comparator and Ancillary ... Active Control Clinical Trials” at the forthcoming US ... the 9th – 10th September, 2014 in Philadelphia, ...
(Date:8/28/2014)... vaccine to prevent Ebola virus disease will begin next ... Diseases (NIAID), part of the National Institutes of Health. ... of a vaccine co-developed by NIAID and GlaxoSmithKline (GSK) ... to generate an immune system response in healthy adults. ... in Bethesda, Maryland. , The study is the first ...
(Date:8/28/2014)... A subset of patients with stage III colon ... therapy, according to a new study in ... the American Gastroenterological Association. , When added to the ... irinotecan therapy improved overall survival rates for patients with ... in about 10 to 20 percent of colorectal cancers. ...
(Date:8/28/2014)... over who identify themselves as ,old, feel worse about ... have lower value than younger age groups. , New ... ,Being old and ill, across different countries: social status, ... from the European Social Survey. Respondents, who were all ... health., The researchers found that those living in societies ...
Breaking Medicine News(10 mins):Health News:Ebola vaccine trials fast-tracked by international consortium 2Health News:Ebola vaccine trials fast-tracked by international consortium 3Health News:Ebola vaccine trials fast-tracked by international consortium 4Health News:Critical Path Sourcing Strategies for Global Clinical Trials Presented by Catalent Experts at US Clinical Trials Supply Conference 2Health News:NIH to Launch human safety study of Ebola vaccine candidate 2Health News:NIH to Launch human safety study of Ebola vaccine candidate 3Health News:NIH to Launch human safety study of Ebola vaccine candidate 4Health News:NIH to Launch human safety study of Ebola vaccine candidate 5Health News:Drug shows promise for subset of stage III colon cancer patients 2
... ALEXANDRIA, Va., July 23 The model for,person-centered long ... to testimony submitted today to the US Senate Special ... care that embraces choice,independence and the opportunity for seniors ... Richard Grimes, the President and CEO,of the Assisted Living ...
... had heart trouble, the worse their performance , , WEDNESDAY, July ... heart disease seem to fare worse on measures of cognitive ... disease, the worse the performance in such mental processes as ... the July 23 issue of the European Heart Journal ...
... Three years after Hurricane Katrina devastated parts of the Gulf ... Public Health Project on the Public and Biological Security shows ... they are very prepared if a major hurricane were to ... worries of respondents threatened or hit by Hurricane Katrina are ...
... Cohen Hired As New CEO, ATLANTA, July 23 ... MELCO Investments LLC, a private business and,real estate investment ... a,substantial capital investment in GMCG. Along with the investment, ... leading colon and rectal,surgeons, as its new CEO., ...
... and Medicare Rules Highlighted; a Focus on Preventing ... Hospital-acquired Conditions, LANSING, ... a national leader in clinical risk management,practice and patient safety programs ... for its annual risk,management conference., The conference will take place ...
... the #1 Healthiest City to,Live and Retire In -, ... voice for 50+ Americans and the world,s largest-circulation,magazine with ... ten,healthiest cities to live and retire in with Ann ... Fargo, ND taking the top five rankings.,Featured in the ...
Cached Medicine News:Health News:ASSISTED LIVING: The Model for Person-Centered Long Term Care 2Health News:Coronary Disease Dulls Cognitive Skills 2Health News:Hurricane preparedness survey: Worries about drinking water and medical care 2Health News:Hurricane preparedness survey: Worries about drinking water and medical care 3Health News:Hurricane preparedness survey: Worries about drinking water and medical care 4Health News:Hurricane preparedness survey: Worries about drinking water and medical care 5Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 2Health News:Greater Medical Center Group Receives Major Funding From MELCO Investments 3Health News:The Risk Management and Patient Safety Institute Announces 2008/2009 Annual Risk Management Conference, Dates 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 2Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 3Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 4Health News:AARP the Magazine Names the Top 10 Healthiest Places to Live in America 5
(Date:8/28/2014)... , Aug. 28, 2014 The Leukemia ... a partnership to advance an experimental cancer vaccine ... an asymptomatic stage of myeloma. The ... through which LLS forges collaborations with biotechnology companies ... OncoPep is developing a vaccine, PVX-410, ...
(Date:8/28/2014)... ANTONIO , Aug. 28, 2014 GenSpera, ... for the treatment of cancer, announces the recent publication ... journal Steroids . The recent article ... reviews the evolution and development of GenSpera,s prodrug technology platform ... of thapsigargin (from the plant Thapsia garganica ) ...
(Date:8/28/2014)... -- STAAR Surgical Company (NASDAQ: STAA ) a leading ... for the eye, today announced that management will present at ... Palace Hotel on Wednesday, September 3 at 7:15 a.m. PT/10:15 ... CEO will offer a general overview of the Company,s current ... by Steve Brown , CFO, and Sam Gesten ...
Breaking Medicine Technology:The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 2GenSpera Media Advisory; "Targeting thapsigargin towards tumors" Published in Steroids 3STAAR Surgical To Present At The Baird 2014 Health Care Conference 2
... -- Concord Medical Services Holdings Limited ("Concord Medical" or ... of the largest network of radiotherapy and diagnostic imaging ... directors approved a share repurchase program, effective immediately. ... States federal securities laws, Concord Medical is authorized to ...
... Sept. 29, 2011 The Educational Review System held ... 28 at the Meyedenbauer Center in Bellevue, WA. Attendees ... pharmacy thought leaders discuss the challenges of pediatric medications, ... the 2010 recipient of the Institute for Safe Medication ...
Cached Medicine Technology:Concord Medical Services Announces Share Repurchase Program 2Concord Medical Services Announces Share Repurchase Program 3
6 mm, 45 degree upwards, detachable....
Aaron 950 is a high frequency desiccator with cut....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
The Sabre 2400 provides high power performance and key user features to meet today's demanding electrosurgical needs. It is an ideal general-purpose electrosurgical generator....
Medicine Products: